Mirati Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
27 Dec 2023	Form 3: EcoR1 Capital, Llc, 10% owner Holds 7,396,979 shares of Common Stock
12 Sep 2023	Form 3: Ondrey Aaron, Interim CFO Holds 14,028 shares of Common Stock
23 Jun 2023	Form 3: Gallagher Carol Giltner, Director Holds 0 shares of Common Stock
23 Jun 2023	Form 3: Moriarty John B, Chief Legal Officer Holds 49,363 shares of Common Stock
08 Nov 2022	Form 3: Sandler Alan B., Chief Medical Officer No securities owned
16 May 2022	Form 3: Stelzer Laurie, CFO Holds 0 shares of Common Stock
24 Sep 2021	Form 3: Meek David D., Director No securities owned
30 Mar 2021	Form 3: Sharp Shalini, Director Holds 0 shares of Common Stock
30 Oct 2020	Form 3: Lockend Five, Llc, 10% owner Holds 203,754 shares of Common Stock
15 Jan 2020	Form 3: Reed Vickie S, SVP, Chief Accounting Officer Holds 5,500 shares of Common Stock
08 Jan 2020	Form 3: Faga Daniel, EVP, Chief Operating Officer No securities owned
08 Jan 2020	Form 3: Hickey Benjamin, EVP, Chief Commercial Officer No securities owned
01 Jul 2019	Form 3: Cherrington Julie M, Director No securities owned
20 Feb 2019	Form 3: Hasnain Faheem, Director
13 Dec 2018	Form 3: Martinez Maria E, Director No securities owned
22 Nov 2017	Form 3: Tuesday Thirteen Inc., 10% owner Holds 1,000 shares of Common Stock
20 Nov 2017	Form 3: Broadfin Healthcare Master Fund Ltd, 10% owner and 2 others Holds 2,788,601 shares of Common Stock
19 Sep 2017	Form 3: venBio Select Advisor Llc, 10% owner and 1 other Holds 3,710,601 shares of Common Stock, $0.001 par value per share (the "Common Stock"
05 Oct 2016	Form 3: Lemasters Christopher C., EVP, CHIEF BUSINESS OFFICER No securities owned
29 Sep 2016	Form 3: Carter Bruce L A, Director No securities owned

Comments